GSK215
- CAS No.
- 2743427-26-9
- Chemical Name:
- GSK215
- Synonyms
- GSK215;(2S,4R)-4-hydroxy-1-((S)-2-(2-(4-(3-methoxy-4-((4-((2-(methylcarbamoyl)phenyl)amino)-5-(trifluoromethyl)pyridin-2-yl)amino)phenyl)piperazin-1-yl)acetamido)-3,3-dimethylbutanoyl)-N-((S)-1-(4-(4-methylthiazol-5-yl)phenyl)ethyl)pyrrolidine-2-carboxamide
- CBNumber:
- CB810705803
- Molecular Formula:
- C50H59F3N10O6S
- Molecular Weight:
- 985.14
- MOL File:
- 2743427-26-9.mol
- Modify Date:
- 2024/7/2 8:55:17
GSK215 Chemical Properties,Uses,Production
in vitro
GSK215 (0.1-1000 nM; 2 h) effectively increases the FAK degradation by >90% and determines a DC50 of 1.3 nM in A549 cells. Its induced degradation is proteasome and ubiquitin-dependent. GSK215 (above 100 nM, 6h) primarily reduces kinases CDK7, RPS6KA3, MET, and GAK. This compound (100 nM, 48 h) inhibits migration, invasion, and collagen deposition in A549 cells.
GSK215 Preparation Products And Raw materials
Raw materials
Preparation Products
GSK215 Suppliers
Global( 39)Suppliers
Supplier | Tel | Country | ProdList | Advantage | Inquiry |
---|---|---|---|---|---|
Hubei Chuchang Biotech Co., Ltd. | +undefined15623860702 | China | 111 | 58 | Inquiry |
Zhejiang J&C Biological Technology Co.,Limited | +1-2135480471 +1-2135480471 | China | 10522 | 58 | Inquiry |
Nantong HI-FUTURE Biology Co., Ltd. | +undefined18051384581 | China | 3136 | 58 | Inquiry |
LEAPCHEM CO., LTD. | +86-852-30606658 | China | 43348 | 58 | Inquiry |
Aladdin Scientific | +1-+1(833)-552-7181 | United States | 52927 | 58 | Inquiry |
Wuhan Jingkang en Biomedical Technology Co., Ltd | +8613720134139 | China | 5225 | 58 | Inquiry |
InvivoChem | 13549236410 | China | 6755 | 58 | Inquiry |
Shanghai Easy CDMO Co.,Ltd | 021-61734564 | China | 10010 | 58 | Inquiry |
TargetMol Chemicals Inc. | 15002134094 | China | 28070 | 58 | Inquiry |
Hubei Kele Fine Chemical Co., Ltd | 027-59101668 19945030958 | China | 7969 | 58 | Inquiry |
2743427-26-9(GSK215)Related Search:
GSK 2033
2-((4-(benzo[d]thiazol-5-ylamino)-6-(tert-butylsulfonyl)quinazolin-7-yl)oxy)ethyl dihydrogen phosphate
N-((S)-1-(4-((S)-2-(2,4-dichlorophenylsulfonaMido)-3-hydroxypropanoyl)piperazin-1-yl)-4-Methyl-1-oxopentan-2-yl)benzo[b]thiophene-2-carboxaMide
GSK-2256098
GSK2837808A
GSK6853
GSK-A1
S)-1-(sec-butyl)-N-((4,6-diMethyl-2-oxo-1,2-dihydropyridin-3-yl)Methyl)-3-Methyl-6-(6-(piperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxaMide
GSK864
GSK484
chevron_left
1of4
chevron_right
GSK215
(2S,4R)-4-hydroxy-1-((S)-2-(2-(4-(3-methoxy-4-((4-((2-(methylcarbamoyl)phenyl)amino)-5-(trifluoromethyl)pyridin-2-yl)amino)phenyl)piperazin-1-yl)acetamido)-3,3-dimethylbutanoyl)-N-((S)-1-(4-(4-methylthiazol-5-yl)phenyl)ethyl)pyrrolidine-2-carboxamide
2743427-26-9
C50H59F3N10O6S